试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
编号:NCT02915263登记状态:提前终止企业 / 申办者:Beth Israel Deaconess Medical Center
药物 / 成分:IGIV-C、0.9% Sodium Chloride
登记的停止原因(原文):Funding withdrawn in the midst of the COVID pandemic
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
编号:NCT03579966登记状态:提前终止企业 / 申办者:Catalyst Pharmaceuticals, Inc.
药物 / 成分:Amifampridine Phosphate
登记的停止原因(原文):Lack of measure appropriate data (MG-ADL).
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
Postpartum Family Planning
编号:NCT03844633登记状态:提前终止企业 / 申办者:Ohio State University
药物 / 成分:Depo-Provera Injectable Product、Placebos
登记的停止原因(原文):Because of insufficient enrollment, we closed the RCT and replaced it with an observational design
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
Desmopressin for Bedwetting in Children With SCD
编号:NCT04420585登记状态:提前终止企业 / 申办者:Montefiore Medical Center
药物 / 成分:Desmopressin
登记的停止原因(原文):Study was not able to meet recruitment after 9 years of trying to enroll patients on different versions of the protocol and changing recruitment strategies.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
Azole-echinocandin Combination Therapy for Invasive Aspergillosis
编号:NCT04876716登记状态:提前终止企业 / 申办者:Erasmus Medical Center
药物 / 成分:Azole、Anidulafungin
登记的停止原因(原文):futility
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
编号:NCT05342623登记状态:提前终止企业 / 申办者:Cara Therapeutics, Inc.
药物 / 成分:Difelikefalin 1 mg Oral Tablet、Placebo Oral Tablet
登记的停止原因(原文):Corporate decision to discontinue work in advanced chronic kidney disease.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-07
CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
编号:NCT05356403登记状态:提前终止企业 / 申办者:Cara Therapeutics, Inc.
药物 / 成分:Difelikefalin 1 mg Oral Tablet、Placebo Oral Tablet
登记的停止原因(原文):Corporate decision to discontinue work in advanced chronic kidney disease
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-06
Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases
编号:NCT02621515登记状态:提前终止企业 / 申办者:University Medical Center Groningen
药物 / 成分:Nivolumab
登记的停止原因(原文):In the Netherlands we wanted to add pilimumab to nivolumab. This resulted in a very long METC procedure which resulted in a to slow inclusion rate.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-06
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
编号:NCT02624388登记状态:提前终止企业 / 申办者:University of Virginia
药物 / 成分:Genistein、Placebo
登记的停止原因(原文):Poor enrollment
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-06
ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain
编号:NCT03261193登记状态:提前终止企业 / 申办者:Nicholas Schott
药物 / 成分:ITM + Sham QLB、ITM + Bupivacaine QLB
登记的停止原因(原文):limited resources for recruitment
查看官方原始记录 ↗